1Narita R, Abe S, Kihara Y, et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol, 2004,41 :132-138.
2Poynard T, Ratziu V, Mchutchison J, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology, 2003,38:75-85.
4Bressler BL, Guindi M, Tomlinson G, et al. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology, 2003,38:639-644.
5Sanyal AJ, Chand N, Comar K, et al. Hyperinsulinemia blocks the inhibition of hepatitis C virus (HCV) replication by interferon: a potential mechanism for failure of interferon therapy in subjects with HCV and nonalcoholic liver disease. Hepatology, 2004,40(4 Suppl 1 ) :179A.
4Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status[J]. Am J Gastroenterol, 2003, 98(9):2060-2063.
5Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium[J]. J Viral Hepal, 1999, 6(1):35-47.
6Tai AW, Chung RT. Treatment failure in hepatitis C: mechanisms of non-response[J]. J Hepat, 2009, 50(2):412-420.
7Conjeevaram HS, Fried MW, Jeffers LJ, et al. Pegintefferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1[J]. Gastroenterology, 2006, 131 (2):470-477.
8Howell CD, Dowling TC, Paul M, et al. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection[J]. Clin Gastroenterol Hepatol, 2008, 6(5):575-583.
9Taylor MW, Tsukahara T, Brodsky L, et al. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy[J]. J Virol, 2007, 81(7):3391-3401.
10Rosen HR, Weston SJ, Im K, et al. Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy[J]. Hepatology, 2007, 46(2):350-358.
